Radiation therapy for unresectable pancreatic adenocarcinoma: population-based trends in utilization and survival rates in the United States

JAMA Surg. 2015 Mar 1;150(3):274-7. doi: 10.1001/jamasurg.2014.1837.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / mortality*
  • Adenocarcinoma / radiotherapy*
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Chemoradiotherapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / drug therapy
  • Pancreatic Neoplasms / mortality*
  • Pancreatic Neoplasms / radiotherapy*
  • Survival Rate
  • United States / epidemiology

Substances

  • Antineoplastic Agents